| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Wei Liu, Jingqi Zhou, Minjuan Cao, Fangming Zhang, Xiaoming Su. A pharmacokinetic analysis of amisulpride in adult Chinese patients with schizophrenia: Impact of creatinine clearance. International journal of clinical pharmacology and therapeutics vol issue 2023 36871243 |
a pharmacokinetic analysis of amisulpride in adult chinese patients with schizophrenia: impact of creatinine clearance. |
2023-03-05 |
2023-03-06 |
Not clear |
| Wagner Antonio Tamagno, Carla Alves, Aline Pompermaier, Francieli Ubirajara \\xc3\\x8dndia Amaral, Nat\\xc3\\xa1lia Freddo, Suelen Mendon\\xc3\\xa7a Soares, Tayllana Schwanke Gon\\xc3\\xa7alves, Lisiane Siqueira, Milena Fortuna, H\\xc3\\xa9vilin Corr\\xc3\\xaaa Dos Santos, Amanda Gorrosterraz\\xc3\\xba, Gustavo Kellermann Reolon, Leonardo Jos\\xc3\\xa9 Gil Barcello. Household based-pyrethroids on adult Zebrafish (Danio rerio) exert behavioral and cholinergic changes in different brain regions. Neurotoxicology vol issue 2023 36868382 |
their behavioral biomarkers indicated a harmful ecological effect on the specie as well as a possible impact of these compounds on autism spectrum disorder (asd) and schizophrenia (szp). |
2023-03-03 |
2023-03-06 |
zebrafish |
| Kenneth L Subotnik, Sarah C McEwen, Joseph Ventura, Luana Rene Turner, Yurika Sturdevant, Trudy L Niess, Laurie R Casaus, Margaret G Distler, Michael F Zito, Gerhard S Hellemann, Clara D Nguyen, Keith H Nuechterlei. Exercise Predicts a Good Night's Sleep: Preliminary Findings from a UCLA Study of First-Episode Schizophrenia. Behavioral sciences (Basel, Switzerland) vol 13 issue 2 2023 36829317 |
understanding the negative impact of poor sleep quality on multiple domains of functioning among persons with schizophrenia is a new frontier of exploration. |
2023-02-25 |
2023-03-06 |
Not clear |
| Gurpreet Rekhi, Young Ern Saw, Keane Lim, Richard S E Keefe, Jimmy Le. Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia. Brain sciences vol 13 issue 2 2023 36831758 |
impact of cognitive impairments on health-related quality of life in schizophrenia. |
2023-02-25 |
2023-03-06 |
Not clear |
| Gurpreet Rekhi, Young Ern Saw, Keane Lim, Richard S E Keefe, Jimmy Le. Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia. Brain sciences vol 13 issue 2 2023 36831758 |
the impact of cognitive impairments on the health-related quality of life (hrqol) in individuals with schizophrenia is unclear. |
2023-02-25 |
2023-03-06 |
Not clear |
| Giacomo Deste, Daniele Corbo, Gabriele Nibbio, Mauro Italia, Dario Dell'Ovo, Irene Calzavara-Pinton, Jacopo Lisoni, Stefano Barlati, Roberto Gasparotti, Antonio Vit. Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review. Brain sciences vol 13 issue 2 2023 36831863 |
impact of physical exercise alone or in combination with cognitive remediation on cognitive functions in people with schizophrenia: a qualitative critical review. |
2023-02-25 |
2023-03-06 |
human |
| Elise Maalouf, Souheil Hallit, Pascale Salameh, Hassan Hossein. Impact of Preexisting Alcohol Use Disorder, Bipolar Disorder, and Schizophrenia on Ischemic Stroke Risk and Severity: A Lebanese Case-Control Study. Healthcare (Basel, Switzerland) vol 11 issue 4 2023 36833072 |
impact of preexisting alcohol use disorder, bipolar disorder, and schizophrenia on ischemic stroke risk and severity: a lebanese case-control study. |
2023-02-25 |
2023-03-06 |
human |
| Juliette Lagreula, Mattia Ferraiolo, Philippe De Timary, Benoit Delatte, Laure Elens, Emmanuel Hermans, Olivia Dalleu. Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia: A Pre-Post Comparison Using Electronic Health Records. Journal of clinical psychopharmacology vol issue 2023 36825857 |
impact of a caffeine restriction policy on inpatients with schizophrenia: a pre-post comparison using electronic health records. |
2023-02-24 |
2023-03-06 |
Not clear |
| Marie-Luise Otte, Mike M Schmitgen, Nadine D Wolf, Katharina M Kubera, Vince D Calhoun, Stefan Fritze, Lena S Geiger, Heike Tost, Ulrich W Seidl, Andreas Meyer-Lindenberg, Dusan Hirjak, Robert Christian Wol. Structure/function interrelationships and illness insight in patients with schizophrenia: a multimodal MRI data fusion study. European archives of psychiatry and clinical neuroscience vol issue 2023 36806586 |
illness insight in schizophrenia (sz) has an important impact on treatment outcome, integration into society and can vary over the course of the disorder. |
2023-02-22 |
2023-03-06 |
Not clear |
| Smith Kashiram Khare, Varun Bajaj, U Rajendra Achary. SchizoNET: a robust and accurate Margenau-Hill time-frequency distribution based deep neural network model for schizophrenia detection using EEG signals. Physiological measurement vol issue 2023 36787641 |
schizophrenia (sz) is a severe chronic illness characterized by delusions, cognitive dysfunctions, and hallucinations that impact feelings, behaviour, and thinking. |
2023-02-14 |
2023-03-06 |
Not clear |
| Heidi C Waters, Robert Stellhorn, Maelys Touya, Heather Fitzgerald, Sandipan Bhattacharjee, Leslie Citrom. The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data. Journal of medical economics vol issue 2023 36780296 |
to evaluate the impact of timing of aripiprazole once-monthly (aom) initiation on healthcare resource utilization (hcru), risk of hospitalization, and healthcare costs in patients with schizophrenia. |
2023-02-13 |
2023-03-06 |
Not clear |
| Ivanka Veleva, Kaloyan Stoychev, Maya Stoimenova-Popova, Eleonora Mineva-Dimitrov. Impact of Cognitive Disturbances and Clinical Symptoms on Disability in Patients with Paranoid Schizophrenia: A Study of a Bulgarian Clinical Sample. International journal of environmental research and public health vol 20 issue 3 2023 36767826 |
the study aimed to assess the impact of clinical symptoms and cognitive impairment on disability in patients with paranoid schizophrenia (ps). |
2023-02-11 |
2023-03-06 |
Not clear |
| Ivanka Veleva, Kaloyan Stoychev, Maya Stoimenova-Popova, Eleonora Mineva-Dimitrov. Impact of Cognitive Disturbances and Clinical Symptoms on Disability in Patients with Paranoid Schizophrenia: A Study of a Bulgarian Clinical Sample. International journal of environmental research and public health vol 20 issue 3 2023 36767826 |
impact of cognitive disturbances and clinical symptoms on disability in patients with paranoid schizophrenia: a study of a bulgarian clinical sample. |
2023-02-11 |
2023-03-06 |
Not clear |
| Daniela L Uliana, Felipe V Gomes, Anthony A Grac. Update on current animal models for schizophrenia: are they still useful? Current opinion in psychiatry vol issue 2023 36762639 |
schizophrenia is a psychiatric disorder that has a significant socioeconomic impact worldwide. |
2023-02-10 |
2023-03-06 |
Not clear |
| Agnus M Kim, Jee Hoon Soh. The impact of the Mental Health Act revision for deinstitutionalization in Korea on the crime rate of people with schizophrenia. Psychiatry research vol 321 issue 2023 36764121 |
the impact of the mental health act revision for deinstitutionalization in korea on the crime rate of people with schizophrenia. |
2023-02-10 |
2023-03-06 |
Not clear |
| Ryan H Purcell, Esra Sefik, Erica Werner, Alexia T King, Trenell J Mosley, Megan E Merritt-Garza, Pankaj Chopra, Zachary T McEachin, Sridhar Karne, Nisha Raj, Kedamawit Tilahun, Maxine Robinette, Stephen T Warren, Zhexing Wen, Victor Faundez, Steven A Sloan, Gary J Bassell, Jennifer G Mull. Cross-species transcriptomic analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion. bioRxiv : the preprint server for biology vol issue 2023 36747819 |
understanding the impact of the 3q29 deletion (3q29del) on the developing cns may therefore lead to insights about the pathobiology of schizophrenia. |
2023-02-07 |
2023-03-06 |
mouse |
| Xiaoling Cheng, Xiaoling Huang, Xinghu Wu, Sulan Li. Impact of the COVID-19 pandemic on lifestyle and mental state in patients with schizophrenia: A retrospective study. Medicine vol 102 issue 5 2023 36749244 |
impact of the covid-19 pandemic on lifestyle and mental state in patients with schizophrenia: a retrospective study. |
2023-02-07 |
2023-03-06 |
human |
| Zhuo-Hui Huang, Fei Wang, Zi-Lang Chen, Yao-Nan Xiao, Qian-Wen Wang, Shi-Bin Wang, Xiao-Yan He, Christine Migliorini, Carol Harvey, Cai-Lan Ho. Risk factors for violent behaviors in patients with schizophrenia: 2-year follow-up study in primary mental health care in China. Frontiers in psychiatry vol 13 issue 2023 36741582 |
the consequences and impact of violent behavior in schizophrenia are often serious, and identification of risk factors is of great importance to achieve early identification and effective management. |
2023-02-06 |
2023-03-06 |
Not clear |
| Giulio Pergola, Nora Penzel, Leonardo Sportelli, Alessandro Bertolin. Lessons Learned From Parsing Genetic Risk for Schizophrenia Into Biological Pathways. Biological psychiatry vol issue 2023 36740470 |
genome-wide association studies in schizophrenia have uncovered a remarkably high number of genetic variants, but the biological pathways they impact upon remain largely unidentified. |
2023-02-05 |
2023-03-06 |
Not clear |
| Yan Yang, Di Kong, Qiwen Li, Wei Chen, Guocheng Zhao, Xi Tan, Xincheng Huang, Zipeng Zhang, Can Feng, Min Xu, Ying Wan, Mi Yan. Non-antipsychotic medicines and modified electroconvulsive therapy are risk factors for hospital-acquired pneumonia in schizophrenia patients. Frontiers in psychiatry vol 13 issue 2023 36713903 |
hospital-acquired pneumonia (hap) has a significant and detrimental impact on schizophrenia patients. |
2023-01-30 |
2023-01-31 |
Not clear |